Key Points Intuitive Surgical's lead in the robot-assisted surgery niche appears unassailable. Sportradar Group is the leading data provider in a rapidly growing market for sports-related information. Investors never know when the next market correction -- a drop of from 10% to 20% in an index -- is coming, but we know that it will eventually happen. And because that's true, it makes sense to make a list of the stocks you'd like to buy if they dip during a correction. The next big market correction could happen next week, next month, or next year. Investors who scoop up shares of Intuitive Surgical(NASDAQ: ISRG) and Sports Radar(NASDAQ: SRAD) if they dip during the inevitable correction could come out miles ahead over the long run. Read on to see why these two belong on growth stock investors' watch lists. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »Image source: Getty Images. Intuitive Surgical Since the turn of the century, Intuitive Surgical has been leading the trend toward minimally invasive surgical procedures performed with the aid of its da Vinci robots. Medtronic and Johnson & Johnson are growing their footprint in this lucrative space, but they generally develop their devices to perform procedures that da Vinci robots haven't already dominated. In 2024, Intuitive Surgical launched an updated system called da Vinci 5, which could significantly reduce procedure times and complications. That combination makes spending over $1 million on a da Vinci system and training surgeons to use it a worthwhile investment for hospitals. During the 12 months that ended this March, the number of da Vinci systems installed worldwide grew 15% to 10,189. All of those da Vinci machines use instruments and accessories that need to be replaced between procedures. First-quarter instrument and accessory sales rose 18% year over year to $1.4 billion. Since Intuitive Surgical is the only company hospitals can buy these instruments from, investors can reasonably expect continued growth at this pace. Shares of Intuitive Surgical have been trading for more than 75 times trailing earnings, and valuations this high aren't unusual for this magnificent growth stock. During the bear market of 2022, though, its valuation sank below 50 times trailing earnings. Folks who keep this one on a watch list and jump on it during the next downturn that takes it down could reap enormous gains over the long run. Sportradar Group Keeping box scores was my favorite part about watching ball games as a kid. So naturally I'm fascinated with Sportradar Group, a company that takes recording and sharing sports statistics to a new level. Story Continues Sportradar is quickly becoming the go-to data provider to media outlets and the growing online sports betting industry. At the end of February, online sports betting was legal in 34 U.S. states, according to the American Gaming Association. Well-established relationships with sports leagues such as Major League Baseball and the Union of European Football Associations give Sportradar a level of access to stadiums that its future competitors won't have. On the data consumption side, Sportradar is already partnered with Flutter Entertainment and DraftKings, which don't have much choice when it comes to information providers. Sportradar grew sales by 26% in 2024 to $1.3 billion, which is just a tiny fraction of the revenue its clients generate with help from its data services. In the U.S. market alone, online sports betting raked in $115 billion last year. Sportsbook (betting) providers rely on accurate data to set lines that don't result in huge losses for the house. As betting during sporting events becomes increasingly normalized, people will demand more information that media outlets can only get from Sportradar. With media outlets and betting operators beating a path to its doors, at least another decade of growth at a double-digit percentage isn't an unreasonable expectation. Sportradar stock has been trading at 22 times management's adjusted EBITDA expectation for 2025. This valuation is high, but it isn't unacceptable for a rapidly growing business with a large growth runway and a lack of competitors. However, I think it would make sense to start only a small position now, then add heavily during the next market correction that brings its valuation down. Should you invest $1,000 in Intuitive Surgical right now? Before you buy stock in Intuitive Surgical, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Intuitive Surgical wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider whenNetflixmade this list on December 17, 2004... if you invested $1,000 at the time of our recommendation,you’d have $623,685!* Or when Nvidiamade this list on April 15, 2005... if you invested $1,000 at the time of our recommendation,you’d have $701,781!* Now, it’s worth notingStock Advisor’s total average return is906% — a market-crushing outperformance compared to164%for the S&P 500. Don’t miss out on the latest top 10 list, available when you joinStock Advisor. See the 10 stocks » *Stock Advisor returns as of May 5, 2025 Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Intuitive Surgical and Sportradar Group Ag. The Motley Fool recommends Flutter Entertainment Plc. The Motley Fool has a disclosure policy. 2 Stocks I Can't Wait to Buy During the Next Market Correction was originally published by The Motley Fool View Comments
2 Stocks I Can't Wait to Buy During the Next Market Correction
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...